Injective (INJ) ranks among the top 100 cryptocurrencies by market value, which makes its long-term price outlook a common question for investors. In this article you will find our INJ forecast for the next 30 days, month by month to 2030, and year by year to 2050 — together with what actually drives the price and the risks that could push it lower.
How to read the tables below: the average is our central estimate for INJ, while the minimum and maximum mark the edges of a plausible range. All 100 coins on ICO Listing Online run through the same model.
Key takeaways
- Rest of 2026: $5.01 to $10.36.
- 2027: $2.84 to $19.77, averaging $7.36.
- 2030: $1.64 to $43.34, averaging $8.28.
- 2040 average: $12.26.
- 2050 average: $18.14.
- Biggest upside driver: monthly community buybacks that reduce supply.
- Biggest risk: user activity is small relative to larger chains.
Table of contents ＋
- INJ price prediction chart
- INJ prediction for the next 30 days
- INJ forecast 2026 – 2050
- Injective price prediction 2026
- November 2026
- December 2026
- Injective price prediction 2027
- Injective price prediction 2028
- Injective price prediction 2029
- Injective price prediction 2030
- Injective price prediction 2031 – 2035
- Injective price prediction 2036 – 2040
- Injective price prediction 2041 – 2045
- Injective price prediction 2046 – 2050
- What is Injective?
- What moves the INJ price
- Can it hit the big targets?
- Conclusion
- FAQ
- Methodology
Injective (INJ) price prediction chart 2026 – 2050
The average INJ forecast for every year to 2050, with the minimum and maximum range around it.
Injective (INJ) price prediction for tomorrow and the next 30 days
Day-by-day forecast for the next 30 days. Each day that passes drops off the table automatically.
| Date | Minimum | Average | Maximum |
|---|---|---|---|
| Nov 3, 2026 | $6.83 | $7.16 | $7.51 |
| Nov 4, 2026 | $6.70 | $7.16 | $7.65 |
| Nov 5, 2026 | $6.60 | $7.16 | $7.77 |
| Nov 6, 2026 | $6.52 | $7.16 | $7.87 |
| Nov 7, 2026 | $6.45 | $7.16 | $7.96 |
| Nov 8, 2026 | $6.38 | $7.16 | $8.04 |
| Nov 9, 2026 | $6.33 | $7.17 | $8.12 |
| Nov 10, 2026 | $6.27 | $7.17 | $8.19 |
| Nov 11, 2026 | $6.22 | $7.17 | $8.25 |
| Nov 12, 2026 | $6.18 | $7.17 | $8.32 |
| Nov 13, 2026 | $6.13 | $7.17 | $8.38 |
| Nov 14, 2026 | $6.09 | $7.17 | $8.44 |
| Nov 15, 2026 | $6.05 | $7.17 | $8.50 |
| Nov 16, 2026 | $6.01 | $7.17 | $8.55 |
| Nov 17, 2026 | $5.98 | $7.17 | $8.61 |
| Nov 18, 2026 | $5.94 | $7.17 | $8.66 |
| Nov 19, 2026 | $5.91 | $7.17 | $8.71 |
| Nov 20, 2026 | $5.87 | $7.17 | $8.76 |
| Nov 21, 2026 | $5.84 | $7.17 | $8.81 |
| Nov 22, 2026 | $5.81 | $7.18 | $8.86 |
| Nov 23, 2026 | $5.78 | $7.18 | $8.90 |
| Nov 24, 2026 | $5.75 | $7.18 | $8.95 |
| Nov 25, 2026 | $5.73 | $7.18 | $9.00 |
| Nov 26, 2026 | $5.70 | $7.18 | $9.04 |
| Nov 27, 2026 | $5.67 | $7.18 | $9.09 |
| Nov 28, 2026 | $5.65 | $7.18 | $9.13 |
| Nov 29, 2026 | $5.62 | $7.18 | $9.17 |
| Nov 30, 2026 | $5.60 | $7.18 | $9.21 |
| Dec 1, 2026 | $5.57 | $7.18 | $9.26 |
| Dec 2, 2026 | $5.55 | $7.18 | $9.30 |
Injective (INJ) price prediction 2026 – 2050
Pick a year to see the month-by-month forecast. Months that have already ended are removed automatically.
| Month | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| November 2026 | $5.59 | $7.18 | $9.23 | +29.0% |
| December 2026 | $5.01 | $7.21 | $10.36 | +44.7% |
Injective (INJ) price prediction 2026
In 2026, INJ could trade between $5.01 and $10.36, averaging around $7.19. The case for the upper end: monthly community buybacks that reduce supply. What could drag it towards the minimum: competition from Hyperliquid and Solana.
| Month | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| November | $5.59 | $7.18 | $9.23 | +29.0% |
| December | $5.01 | $7.21 | $10.36 | +44.7% |
Injective price prediction for November 2026
For November 2026, expect a range of roughly $5.59 to $9.23 (average $7.18).
Injective price prediction for December 2026
In December 2026, INJ could range from $5.01 to $10.36, with an average around $7.21.
Injective (INJ) price prediction 2027
Our Injective forecast for 2027 is a range of $2.84 to $19.77, with $7.36 as the average. What could lift it towards the top of that range: developers using the native EVM. On the downside, keep in mind: buyback size depends on fee revenue, which falls in quiet markets.
| Month | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| January | $4.62 | $7.23 | $11.32 | +58.0% |
| February | $4.34 | $7.25 | $12.11 | +69.1% |
| March | $4.09 | $7.28 | $12.94 | +80.7% |
| April | $3.88 | $7.30 | $13.72 | +91.6% |
| May | $3.70 | $7.32 | $14.50 | +102.6% |
| June | $3.54 | $7.35 | $15.25 | +113.0% |
| July | $3.39 | $7.37 | $16.02 | +123.7% |
| August | $3.26 | $7.40 | $16.78 | +134.3% |
| September | $3.14 | $7.42 | $17.51 | +144.6% |
| October | $3.03 | $7.44 | $18.27 | +155.2% |
| November | $2.93 | $7.47 | $19.01 | +165.5% |
| December | $2.84 | $7.49 | $19.77 | +176.2% |
Injective (INJ) price prediction 2028
For 2028, our model puts Injective between $2.07 and $29.30, with an average of $7.66. Upside driver to watch: tokenised asset and derivatives markets. The main downside risk: user activity is small relative to larger chains.
| Month | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| January | $2.75 | $7.52 | $20.54 | +186.9% |
| February | $2.68 | $7.54 | $21.27 | +197.0% |
| March | $2.60 | $7.57 | $22.04 | +207.9% |
| April | $2.53 | $7.59 | $22.80 | +218.5% |
| May | $2.46 | $7.62 | $23.60 | +229.6% |
| June | $2.40 | $7.64 | $24.37 | +240.4% |
| July | $2.33 | $7.67 | $25.18 | +251.7% |
| August | $2.28 | $7.69 | $25.99 | +263.0% |
| September | $2.22 | $7.72 | $26.79 | +274.2% |
| October | $2.17 | $7.74 | $27.63 | +285.8% |
| November | $2.12 | $7.77 | $28.44 | +297.2% |
| December | $2.07 | $7.79 | $29.30 | +309.2% |
Injective (INJ) price prediction 2029
In 2029, INJ could trade between $1.68 and $39.01, averaging around $7.96. The case for the upper end: monthly community buybacks that reduce supply. What could drag it towards the minimum: competition from Hyperliquid and Solana.
| Month | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| January | $2.03 | $7.82 | $30.16 | +321.2% |
| February | $1.99 | $7.84 | $30.95 | +332.2% |
| March | $1.95 | $7.87 | $31.83 | +344.6% |
| April | $1.91 | $7.90 | $32.70 | +356.6% |
| May | $1.87 | $7.92 | $33.60 | +369.3% |
| June | $1.83 | $7.95 | $34.49 | +381.7% |
| July | $1.80 | $7.97 | $35.42 | +394.7% |
| August | $1.76 | $8.00 | $36.36 | +407.8% |
| September | $1.73 | $8.03 | $37.28 | +420.7% |
| October | $1.70 | $8.05 | $38.24 | +434.1% |
| November | $1.69 | $8.08 | $38.64 | +439.6% |
| December | $1.68 | $8.11 | $39.01 | +444.9% |
Injective (INJ) price prediction 2030
Our Injective forecast for 2030 is a range of $1.64 to $43.34, with $8.28 as the average. What could lift it towards the top of that range: developers using the native EVM. On the downside, keep in mind: buyback size depends on fee revenue, which falls in quiet markets.
| Month | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| January | $1.68 | $8.13 | $39.39 | +450.1% |
| February | $1.68 | $8.16 | $39.73 | +454.8% |
| March | $1.67 | $8.18 | $40.10 | +460.0% |
| April | $1.67 | $8.21 | $40.46 | +465.0% |
| May | $1.66 | $8.24 | $40.83 | +470.2% |
| June | $1.66 | $8.26 | $41.18 | +475.2% |
| July | $1.66 | $8.29 | $41.55 | +480.3% |
| August | $1.65 | $8.32 | $41.91 | +485.4% |
| September | $1.65 | $8.35 | $42.27 | +490.3% |
| October | $1.65 | $8.37 | $42.63 | +495.4% |
| November | $1.64 | $8.40 | $42.98 | +500.3% |
| December | $1.64 | $8.43 | $43.34 | +505.3% |
Injective (INJ) price prediction 2031 – 2035
From 2031 to 2035, Injective's average path climbs from $8.61 to $10.07. Forecasts this far ahead are highly uncertain, which is why the minimum and maximum columns are so far apart. Long-term upside: monthly community buybacks that reduce supply. Long-term risk: buyback size depends on fee revenue, which falls in quiet markets.
| Year | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| 2031 | $1.62 | $8.61 | $47.56 | +564.3% |
| 2032 | $1.61 | $8.96 | $51.78 | +623.1% |
| 2033 | $1.60 | $9.31 | $56.02 | +682.4% |
| 2034 | $1.61 | $9.69 | $60.34 | +742.8% |
| 2035 | $1.61 | $10.07 | $64.77 | +804.7% |
Injective (INJ) price prediction 2036 – 2040
Between 2036 and 2040, the model's average for INJ moves from $10.48 to $12.26. Treat these as rough markers: a lot can change for any crypto project over a decade or more. Long-term upside: developers using the native EVM. Long-term risk: user activity is small relative to larger chains.
| Year | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| 2036 | $1.63 | $10.48 | $69.35 | +868.5% |
| 2037 | $1.64 | $10.90 | $74.06 | +934.3% |
| 2038 | $1.66 | $11.33 | $78.93 | +1002.4% |
| 2039 | $1.69 | $11.78 | $83.99 | +1073.1% |
| 2040 | $1.72 | $12.26 | $89.26 | +1146.6% |
Injective (INJ) price prediction 2041 – 2045
Looking further out, our Injective forecast for 2041 to 2045 rises from an average of $12.75 to $14.91. Over a horizon this long, the range matters more than any single number. Long-term upside: tokenised asset and derivatives markets. Long-term risk: competition from Hyperliquid and Solana.
| Year | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| 2041 | $1.75 | $12.75 | $94.72 | +1222.9% |
| 2042 | $1.78 | $13.26 | $100.41 | +1302.4% |
| 2043 | $1.82 | $13.79 | $106.34 | +1385.1% |
| 2044 | $1.86 | $14.34 | $112.53 | +1471.6% |
| 2045 | $1.90 | $14.91 | $118.97 | +1561.6% |
Injective (INJ) price prediction 2046 – 2050
From 2046 to 2050, Injective's average path climbs from $15.51 to $18.14. Forecasts this far ahead are highly uncertain, which is why the minimum and maximum columns are so far apart. Long-term upside: monthly community buybacks that reduce supply. Long-term risk: buyback size depends on fee revenue, which falls in quiet markets.
| Year | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| 2046 | $1.94 | $15.51 | $125.69 | +1655.5% |
| 2047 | $1.99 | $16.13 | $132.71 | +1753.4% |
| 2048 | $2.04 | $16.77 | $140.05 | +1856.0% |
| 2049 | $2.09 | $17.44 | $147.69 | +1962.8% |
| 2050 | $2.14 | $18.14 | $155.68 | +2074.3% |
What is Injective?
Injective is a layer 1 built for financial applications such as exchanges and derivatives, using the Cosmos SDK. A monthly Community BuyBack, which replaced the weekly burn auction in 2025, uses protocol fees to buy and destroy INJ, and the network added a native EVM in 2025.
What moves the INJ price
What could push INJ higher
- Monthly community buybacks that reduce supply.
- Developers using the native EVM.
- Tokenised asset and derivatives markets.
What could push INJ lower
- User activity is small relative to larger chains.
- Competition from Hyperliquid and Solana.
- Buyback size depends on fee revenue, which falls in quiet markets.
What we are watching: Monthly buyback-and-burn amounts.
Can Injective hit the big price targets?
Headlines often ask whether Injective can “reach” a round number. Our model can put a rough probability on it. Treat these as orders of magnitude, not precise odds.
- At or above $20.00 at end of 2030about 30%
- At or above $50.00 at end of 2030about 14%
Conclusion
So where does that leave INJ? On our numbers, somewhere between $1.64 and $43.34 by 2030, with a long-run average of $18.14 by 2050. Which end it reaches depends far more on monthly community buybacks that reduce supply than on any chart pattern. The single metric we would keep an eye on: monthly buyback-and-burn amounts.
